Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

PVLA US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

PVLA US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Palvella Therapeutics, Inc.(PVLA US)

$162.28+9.356.11%Ext:$155.90-6.383.93%(Pre-Market · 13:33:21 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Categorized

Palvella Therapeutics, Inc.(PVLA US)

$162.28+9.356.11%Ext:$155.90-6.383.93%(Pre-Market · 13:33:21 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Categorized
Chronological
By Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees
Chronological
By Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees

SEC Filings

SEC Filings

Financials(63)

Expand
  • 10-QQ3ended 30 Sept 202608:00AM
  • 10-QQ2ended 30 Jun 20264 Aug
  • 10-QQ1ended 31 Mar 20267 May
  • 10-KFY 2025ended 31 Dec 202531 Mar
  • 10-QQ3ended 30 Sept 202512 Nov 2025
  • 10-QQ2ended 30 Jun 202514 Aug 2025
  • 10-QQ1ended 31 Mar 202515 May 2025
  • 10-KFY 2024ended 31 Dec 202431 Mar 2025
  • 10-QQ3ended 30 Sept 202413 Nov 2024
  • 10-QQ2ended 30 Jun 202414 Aug 2024
  • 10-QQ1ended 31 Mar 202415 May 2024
  • 10-K/AFY 2023ended 31 Dec 202329 Apr 2024
  • 10-KFY 2023ended 31 Dec 202329 Mar 2024
  • 10-QQ3ended 30 Sept 202314 Nov 2023
  • 10-QQ2ended 30 Jun 202310 Aug 2023

Events(217)

Expand
  • 8-KResults of Operations and Financial Condition07:30AM
  • 8-KEX-PRESS RELEASE ISSUED BY PALVELLA THERAPEUTICS, INC. ON OCTOBER 28, 202628 Oct
  • 8-KResults of Operations and Financial Condition4 Aug
  • 8-KEX-PALVELLA THERAPEUTICS CORPORATE PRESENTATION - JULY 202614 Jul
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers30 Jun
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers16 Jun
  • 8-KPRESS RELEASE ISSUED BY PALVELLA THERAPEUTICS, INC. ON MAY 20, 202620 May
  • 8-KPRESS RELEASE ISSUED BY PALVELLA THERAPEUTICS, INC. ON MAY 15, 202615 May
  • 8-KOther Events13 May
  • 8-KResults of Operations and Financial Condition7 May
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers13 Apr
  • 8-KEX-PALVELLA THERAPEUTICS CORPORATE PRESENTATION - APRIL 20267 Apr
  • 8-KResults of Operations and Financial Condition31 Mar
  • 8-KEntry into a Material Definitive Agreement26 Feb
  • 8-KResults of Operations and Financial Condition24 Feb

Insider Ownership(251)

Expand
  • 4Goin Kathleen23 Oct
  • 4JENKINS GEORGE M14 Oct
  • 4Goin Kathleen18 Sep
  • 4JENKINS GEORGE M15 Sep
  • 4KIRITSY CHRISTOPHER P4 Sep
  • 4Goin Kathleen20 Aug
  • 4Goin Kathleen17 Jul
  • 4Pauls Matthew1 Jul
  • 3Pauls Matthew1 Jul
  • 4Goin Kathleen22 Jun
  • 4Korenberg Matthew E16 Jun
  • 4KIRITSY CHRISTOPHER P12 Jun
  • 4JENKINS GEORGE M12 Jun
  • 4HERON ELAINE J12 Jun
  • 4Doux John12 Jun

Beneficial Ownership(87)

Expand
  • SC 13G/APALVELLA THERAPEUTICS, INC.28 Oct
  • SC 13G/APALVELLA THERAPEUTICS, INC.14 Aug
  • SC 13G/APALVELLA THERAPEUTICS, INC.14 Aug
  • SC 13GPALVELLA THERAPEUTICS, INC.10 Aug
  • SC 13GPALVELLA THERAPEUTICS, INC.3 Aug
  • SC 13GPALVELLA THERAPEUTICS, INC.29 Jul
  • SC 13GPALVELLA THERAPEUTICS, INC.17 Feb
  • SC 13G/APALVELLA THERAPEUTICS, INC.17 Feb
  • SC 13G/APALVELLA THERAPEUTICS, INC.13 Feb
  • SC 13G/APALVELLA THERAPEUTICS, INC.14 Nov 2025
  • SC 13G/APALVELLA THERAPEUTICS, INC.13 Nov 2025
  • SC 13G/APALVELLA THERAPEUTICS, INC.14 Aug 2025
  • SC 13G/APALVELLA THERAPEUTICS, INC.14 Aug 2025
  • SC 13G/APALVELLA THERAPEUTICS, INC.15 May 2025
  • SC 13GPALVELLA THERAPEUTICS, INC.8 Jan 2025

Other Ownership(16)

Expand
  • 144Goin Kathleen21 Oct
  • 144JENKINS GEORGE M13 Oct
  • 144Goin Kathleen16 Sep
  • 144JENKINS GEORGE M11 Sep
  • 144KIRITSY CHRISTOPHER P2 Sep
  • 144Goin Kathleen19 Aug
  • 144Goin Kathleen15 Jul
  • 144Goin Kathleen17 Jun
  • 144Goin Kathleen20 May
  • 144Goin Kathleen15 Apr
  • 144Goin Kathleen18 Mar
  • 144/AGoin Kathleen19 Feb
  • 144Goin Kathleen18 Feb
  • 144Goin Kathleen21 Jan
  • 144Goin Kathleen17 Dec 2025

Proxies(26)

Expand
  • ARSAnnual report to security holders30 Apr
  • DEFA14ADefinitive additional materials30 Apr
  • DEF 14ADefinitive proxy statement30 Apr
  • ARSAnnual report to security holders30 Apr 2025
  • DEFA14ADefinitive additional materials30 Apr 2025
  • DEF 14ADefinitive proxy statement30 Apr 2025
  • ARSAnnual report to security holders6 Nov 2024
  • DEF 14ADefinitive proxy statement6 Nov 2024
  • DEFA14ADefinitive additional materials28 Apr 2023
  • ARSAnnual report to security holders28 Apr 2023
  • DEF 14ADefinitive proxy statement28 Apr 2023
  • DEFA14ADefinitive additional materials29 Apr 2022
  • DEF 14ADefinitive proxy statement29 Apr 2022
  • DEFA14ADefinitive additional materials29 Apr 2021
  • DEF 14ADefinitive proxy statement29 Apr 2021

Registrations(80)

Expand
  • S-8Registration statement (employee benefit plan)4 Aug
  • 424B5Prospectus filing (Rule 424(b)(5))26 Feb
  • 424B5Prospectus filing (Rule 424(b)(5))24 Feb
  • S-3Registration statement (primary offering)2 Jan
  • S-8Registration statement (employee benefit plan)18 Feb 2025
  • 424B3Prospectus filing (Rule 424(b)(3))17 Jan 2025
  • S-1/ARegistration statement (general form, amendment)14 Jan 2025
  • S-1Registration statement (general form)31 Dec 2024
  • 425Business combination communication12 Dec 2024
  • 425Business combination communication3 Dec 2024
  • 424B3Prospectus filing (Rule 424(b)(3))8 Nov 2024
  • S-4/ARegistration statement (business combination, amendment)7 Nov 2024
  • 425Business combination communication7 Nov 2024
  • S-4/ARegistration statement (business combination, amendment)5 Nov 2024
  • S-4/ARegistration statement (business combination, amendment)29 Oct 2024

Filing Review Correspondence(19)

Expand
  • CORRESPFiling review correspondence27 Jan
  • CORRESPFiling review correspondence15 Jan 2025
  • CORRESPFiling review correspondence7 Nov 2024
  • CORRESPFiling review correspondence5 Nov 2024
  • CORRESPFiling review correspondence29 Oct 2024
  • CORRESPFiling review correspondence15 Oct 2024
  • CORRESPFiling review correspondence23 Sep 2024
  • CORRESPFiling review correspondence11 Aug 2021
  • CORRESPFiling review correspondence26 May 2021
  • CORRESPFiling review correspondence11 Dec 2019
  • CORRESPFiling review correspondence21 Aug 2018
  • CORRESPFiling review correspondence2 Aug 2016
  • CORRESPFiling review correspondence2 Aug 2016
  • CORRESPFiling review correspondence2 Aug 2016
  • CORRESPFiling review correspondence26 Jun 2015

SEC Orders And Notices(32)

Expand
  • EFFECTNotice of effectiveness30 Jan
  • EFFECTNotice of effectiveness16 Jan 2025
  • EFFECTNotice of effectiveness8 Nov 2024
  • CT ORDERConfidential treatment order3 Jan 2023
  • CT ORDERConfidential treatment order3 Jan 2023
  • CT ORDERConfidential treatment order3 Jan 2023
  • CT ORDERConfidential treatment order16 Dec 2022
  • EFFECTNotice of effectiveness13 Aug 2021
  • EFFECTNotice of effectiveness28 May 2021
  • CT ORDERConfidential treatment order7 Aug 2020
  • CT ORDERConfidential treatment order12 May 2020
  • CT ORDERConfidential treatment order21 Jan 2020
  • CT ORDERConfidential treatment order21 Jan 2020
  • EFFECTNotice of effectiveness12 Dec 2019
  • CT ORDERConfidential treatment order11 Jul 2019

Exempt Offerings(4)

Expand
  • D06b20 Nov 2019
  • D06b15 Jun 2016
  • D06b31 Dec 2014
  • D06b31 Dec 2014

Other(3)

Expand
  • SEC STAFF LETTERSEC STAFF LETTER12 Nov 2024
  • SEC STAFF LETTERSEC STAFF LETTER25 Oct 2024
  • CERTNASAUTO-GENERATED PAPER DOCUMENT25 Jun 2015

Financials(63)

Expand
  • 10-QQ3ended 30 Sept 202608:00AM
  • 10-QQ2ended 30 Jun 20264 Aug
  • 10-QQ1ended 31 Mar 20267 May
  • 10-KFY 2025ended 31 Dec 202531 Mar
  • 10-QQ3ended 30 Sept 202512 Nov 2025
  • 10-QQ2ended 30 Jun 202514 Aug 2025
  • 10-QQ1ended 31 Mar 202515 May 2025
  • 10-KFY 2024ended 31 Dec 202431 Mar 2025
  • 10-QQ3ended 30 Sept 202413 Nov 2024
  • 10-QQ2ended 30 Jun 202414 Aug 2024
  • 10-QQ1ended 31 Mar 202415 May 2024
  • 10-K/AFY 2023ended 31 Dec 202329 Apr 2024
  • 10-KFY 2023ended 31 Dec 202329 Mar 2024
  • 10-QQ3ended 30 Sept 202314 Nov 2023
  • 10-QQ2ended 30 Jun 202310 Aug 2023

Events(217)

Expand
  • 8-KResults of Operations and Financial Condition07:30AM
  • 8-KEX-PRESS RELEASE ISSUED BY PALVELLA THERAPEUTICS, INC. ON OCTOBER 28, 202628 Oct
  • 8-KResults of Operations and Financial Condition4 Aug
  • 8-KEX-PALVELLA THERAPEUTICS CORPORATE PRESENTATION - JULY 202614 Jul
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers30 Jun
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers16 Jun
  • 8-KPRESS RELEASE ISSUED BY PALVELLA THERAPEUTICS, INC. ON MAY 20, 202620 May
  • 8-KPRESS RELEASE ISSUED BY PALVELLA THERAPEUTICS, INC. ON MAY 15, 202615 May
  • 8-KOther Events13 May
  • 8-KResults of Operations and Financial Condition7 May
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers13 Apr
  • 8-KEX-PALVELLA THERAPEUTICS CORPORATE PRESENTATION - APRIL 20267 Apr
  • 8-KResults of Operations and Financial Condition31 Mar
  • 8-KEntry into a Material Definitive Agreement26 Feb
  • 8-KResults of Operations and Financial Condition24 Feb

Insider Ownership(251)

Expand
  • 4Goin Kathleen23 Oct
  • 4JENKINS GEORGE M14 Oct
  • 4Goin Kathleen18 Sep
  • 4JENKINS GEORGE M15 Sep
  • 4KIRITSY CHRISTOPHER P4 Sep
  • 4Goin Kathleen20 Aug
  • 4Goin Kathleen17 Jul
  • 4Pauls Matthew1 Jul
  • 3Pauls Matthew1 Jul
  • 4Goin Kathleen22 Jun
  • 4Korenberg Matthew E16 Jun
  • 4KIRITSY CHRISTOPHER P12 Jun
  • 4JENKINS GEORGE M12 Jun
  • 4HERON ELAINE J12 Jun
  • 4Doux John12 Jun

Beneficial Ownership(87)

Expand
  • SC 13G/APALVELLA THERAPEUTICS, INC.28 Oct
  • SC 13G/APALVELLA THERAPEUTICS, INC.14 Aug
  • SC 13G/APALVELLA THERAPEUTICS, INC.14 Aug
  • SC 13GPALVELLA THERAPEUTICS, INC.10 Aug
  • SC 13GPALVELLA THERAPEUTICS, INC.3 Aug
  • SC 13GPALVELLA THERAPEUTICS, INC.29 Jul
  • SC 13GPALVELLA THERAPEUTICS, INC.17 Feb
  • SC 13G/APALVELLA THERAPEUTICS, INC.17 Feb
  • SC 13G/APALVELLA THERAPEUTICS, INC.13 Feb
  • SC 13G/APALVELLA THERAPEUTICS, INC.14 Nov 2025
  • SC 13G/APALVELLA THERAPEUTICS, INC.13 Nov 2025
  • SC 13G/APALVELLA THERAPEUTICS, INC.14 Aug 2025
  • SC 13G/APALVELLA THERAPEUTICS, INC.14 Aug 2025
  • SC 13G/APALVELLA THERAPEUTICS, INC.15 May 2025
  • SC 13GPALVELLA THERAPEUTICS, INC.8 Jan 2025

Other Ownership(16)

Expand
  • 144Goin Kathleen21 Oct
  • 144JENKINS GEORGE M13 Oct
  • 144Goin Kathleen16 Sep
  • 144JENKINS GEORGE M11 Sep
  • 144KIRITSY CHRISTOPHER P2 Sep
  • 144Goin Kathleen19 Aug
  • 144Goin Kathleen15 Jul
  • 144Goin Kathleen17 Jun
  • 144Goin Kathleen20 May
  • 144Goin Kathleen15 Apr
  • 144Goin Kathleen18 Mar
  • 144/AGoin Kathleen19 Feb
  • 144Goin Kathleen18 Feb
  • 144Goin Kathleen21 Jan
  • 144Goin Kathleen17 Dec 2025

Proxies(26)

Expand
  • ARSAnnual report to security holders30 Apr
  • DEFA14ADefinitive additional materials30 Apr
  • DEF 14ADefinitive proxy statement30 Apr
  • ARSAnnual report to security holders30 Apr 2025
  • DEFA14ADefinitive additional materials30 Apr 2025
  • DEF 14ADefinitive proxy statement30 Apr 2025
  • ARSAnnual report to security holders6 Nov 2024
  • DEF 14ADefinitive proxy statement6 Nov 2024
  • DEFA14ADefinitive additional materials28 Apr 2023
  • ARSAnnual report to security holders28 Apr 2023
  • DEF 14ADefinitive proxy statement28 Apr 2023
  • DEFA14ADefinitive additional materials29 Apr 2022
  • DEF 14ADefinitive proxy statement29 Apr 2022
  • DEFA14ADefinitive additional materials29 Apr 2021
  • DEF 14ADefinitive proxy statement29 Apr 2021

Registrations(80)

Expand
  • S-8Registration statement (employee benefit plan)4 Aug
  • 424B5Prospectus filing (Rule 424(b)(5))26 Feb
  • 424B5Prospectus filing (Rule 424(b)(5))24 Feb
  • S-3Registration statement (primary offering)2 Jan
  • S-8Registration statement (employee benefit plan)18 Feb 2025
  • 424B3Prospectus filing (Rule 424(b)(3))17 Jan 2025
  • S-1/ARegistration statement (general form, amendment)14 Jan 2025
  • S-1Registration statement (general form)31 Dec 2024
  • 425Business combination communication12 Dec 2024
  • 425Business combination communication3 Dec 2024
  • 424B3Prospectus filing (Rule 424(b)(3))8 Nov 2024
  • S-4/ARegistration statement (business combination, amendment)7 Nov 2024
  • 425Business combination communication7 Nov 2024
  • S-4/ARegistration statement (business combination, amendment)5 Nov 2024
  • S-4/ARegistration statement (business combination, amendment)29 Oct 2024

Filing Review Correspondence(19)

Expand
  • CORRESPFiling review correspondence27 Jan
  • CORRESPFiling review correspondence15 Jan 2025
  • CORRESPFiling review correspondence7 Nov 2024
  • CORRESPFiling review correspondence5 Nov 2024
  • CORRESPFiling review correspondence29 Oct 2024
  • CORRESPFiling review correspondence15 Oct 2024
  • CORRESPFiling review correspondence23 Sep 2024
  • CORRESPFiling review correspondence11 Aug 2021
  • CORRESPFiling review correspondence26 May 2021
  • CORRESPFiling review correspondence11 Dec 2019
  • CORRESPFiling review correspondence21 Aug 2018
  • CORRESPFiling review correspondence2 Aug 2016
  • CORRESPFiling review correspondence2 Aug 2016
  • CORRESPFiling review correspondence2 Aug 2016
  • CORRESPFiling review correspondence26 Jun 2015

SEC Orders And Notices(32)

Expand
  • EFFECTNotice of effectiveness30 Jan
  • EFFECTNotice of effectiveness16 Jan 2025
  • EFFECTNotice of effectiveness8 Nov 2024
  • CT ORDERConfidential treatment order3 Jan 2023
  • CT ORDERConfidential treatment order3 Jan 2023
  • CT ORDERConfidential treatment order3 Jan 2023
  • CT ORDERConfidential treatment order16 Dec 2022
  • EFFECTNotice of effectiveness13 Aug 2021
  • EFFECTNotice of effectiveness28 May 2021
  • CT ORDERConfidential treatment order7 Aug 2020
  • CT ORDERConfidential treatment order12 May 2020
  • CT ORDERConfidential treatment order21 Jan 2020
  • CT ORDERConfidential treatment order21 Jan 2020
  • EFFECTNotice of effectiveness12 Dec 2019
  • CT ORDERConfidential treatment order11 Jul 2019

Exempt Offerings(4)

Expand
  • D06b20 Nov 2019
  • D06b15 Jun 2016
  • D06b31 Dec 2014
  • D06b31 Dec 2014

Other(3)

Expand
  • SEC STAFF LETTERSEC STAFF LETTER12 Nov 2024
  • SEC STAFF LETTERSEC STAFF LETTER25 Oct 2024
  • CERTNASAUTO-GENERATED PAPER DOCUMENT25 Jun 2015